Comparison of clinical and biochemical variables in type 2 diabetes mellitus patients and their first-degree relatives with metabolic syndrome in Benin City, Nigeria: A cross sectional case controlled study

Adediran OS, Ohwovoriole AE. Prevalence of the metabolic syndrome among Nigerians with type 2 diabetes mellitus. Poster presentation. 18^th International Diabetes Federation Congress on Diabetes Metabolism, August 24–29, Paris, France, 4s30–4s31, 2003.Search in Google Scholar

Alberti KG, Zimmet P, Shaw J. Metabolic syndrome – a new worldwide definition. A Consensus Statement from the International Diabetes Federation. Diabetes Med 23, 460–469, 2006.10.1111/j.1464-5491.2006.01858.x16681555Search in Google Scholar

Alebiosu OC, Odusan BO. Metabolic syndrome in subjects with type 2 diabetes mellitus. J Natl Med Assoc 96, 817–821, 2004.Search in Google Scholar

Chaiken RL, Banerji MA, Huey H, Levbovit HE. Do Blacks with NIDDM have an insulin-resistance syndrome? Diabetes 42, 444–449, 1993.10.2337/diabetes.42.3.444Search in Google Scholar

Elbein SC, Maxwell TM, Schumacher MC. Insulin and glucose levels and prevalence of glucose intolerance in pedigrees with multiple diabetic siblings. Diabetes 40, 1024–1032, 1991.10.2337/diabetes.40.8.1024Search in Google Scholar

Eregie A, Edo A. Diagnosing the metabolic syndrome: A comparative evaluation of three Diagnostic tools. Poster presentation. 19^thWorld Diabetes Congress, International Diabetes Federation. December 3–7, 2006. Cape Town, South Africa. Diabetic Medicine 23(Supp l4), 2006.Search in Google Scholar

Ginner V, Coca A, Sierra A. Increased insulin resistance in salt-sensitive hypertension. J Hum Hypertens 15, 481–485, 2001.10.1038/sj.jhh.100121611464258Search in Google Scholar

Gulli G, Ferrannini E, Stern M, Haffner S, DeFronzo RA. The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents. Diabetes 41, 1575–1586, 1992.10.2337/diabetes.41.12.1575Search in Google Scholar

Hotamisligil GS. The role of TNF-alpha and TNF receptors in obesity and insulin resistance. J Intem Med 245, 621–625, 1999.10.1046/j.1365-2796.1999.00490.x10395191Search in Google Scholar

Karaman A, Bayram F, Gundogan K, Ozsan M, Karaman H, Kelestimur F. Prevalence of diabetes mellitus and glucose metabolism disorders in the first degree relatives of type 2 diabetic patients. Bratisl Lek Listy 113, 361–367, 2012.10.4149/BLL_2012_082Search in Google Scholar

Ma H, Gong Y, Liu YY, Song J, Tian HM, Chen T, Ran XW. Prevalence of diabetes and prediabetes mellitus in the first-degree relatives of patients with type 2 diabetes in Chengdu. Sichuan Da Xue Xue Bao Yi Xue Ba 42, 264–268, 2011.Search in Google Scholar

Mohsin A, Zafar J, Imran SM, Zaheer K, Khizar B, Qazi R A. Frequency of the metabolic syndrome in adult type2 diabetics presenting to Pakistan Institute of Medical Sciences. J Pak Med Assoc 57, 235–238, 2007.Search in Google Scholar

Ogbera AO. Prevalence and gender distribution of the metabolic syndrome. Diabetol Metab Syndr 2, 1, 2010.10.1186/1758-5996-2-1283698320180954Search in Google Scholar

Osuji CU, Nzerem BA, Dioka CE, Onwubuya EI. Metabolic syndrome in newly diagnosed type 2 diabetes mellitus using NCEP-ATP III, the Nnewi experience. Nig J of Clin Prac 15, 475–480, 2012.10.4103/1119-3077.10453023238201Search in Google Scholar

Pyorala K. Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland. Diabetes Care 2, 131–141, 1979.10.2337/diacare.2.2.131520116Search in Google Scholar

Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37, 1595–1607, 1988.10.2337/diabetes.37.12.1595Search in Google Scholar

Rosolova H. The sympathetic nervous system and insulin resistance. Vnitr Lek 49, 61–65, 2003.Search in Google Scholar

Shaw JT, Purdie DM, Neil HA, Levy JC, Turner RC. The relative risks of hyperglycaemia, obesity and dyslipidaemia in the relatives of patients with Type II diabetes mellitus. Diabetologia 42, 24–27, 1999.10.1007/s00125005110710027573Search in Google Scholar

Siewert S, Filipuzzi S, Codazzi L, Gonzalez I, Ojeda MS. Impact of metabolic syndrome risk factors in first-degree relatives of type2 diabetic patients. Rev Diabet Stud 4, 117–184, 2007.10.1900/RDS.2007.4.177217406018084675Search in Google Scholar

Stewart MW, Humphriss DB, Berrish TS, Barriocanal LA, Trajano LR, Alberti KG, Walker M. Features of syndrome X in first-degree relatives of NIDDM patients. Diabetes Care 18, 1020–1022, 1995.10.2337/diacare.18.7.10207555535Search in Google Scholar

The IDF consensus worldwide definition of the metabolic syndrome. 2006. http://www.idf.org/webdata/docs/idf_meta_def_final.pdf.Search in Google Scholar

The Metabolic Syndrome, WHO criteria. 1999. https://www.staff.ncl.ac.uk/philip.home/who_dmc.htm/who_dmg.pdf#DefinDiagSearch in Google Scholar

Trinder P. Determination of glucose in blood using the glucose oxidase with an alternative oxygen acceptor. Ann Clin Biochem 6, 24–27, 1969.10.1177/000456326900600108Search in Google Scholar

Verges BL. Dyslipidemia in diabetes mellitus. Review of the main lipoprotein abnormalities and their consequences on the development of atherogenesis. Diabetes Metab 25, 32–40, 1999.Search in Google Scholar

Wellborn TA, Wearne K. Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care 2, 154–160, 1976.10.2337/diacare.2.2.154520119Search in Google Scholar

WHO Technical Report Series-854. Physical Status: The use and interpretation of Anthropometry. WHO Geneva1995.Search in Google Scholar

Zimmet P, Albert G, Shaw J. A new IDF worldwide definition of the metabolic syndrome: the rationale and the results. Diabetes Voice 50, 31–33, 2005.Search in Google Scholar